Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S458000, C549S398000, C549S406000
Reexamination Certificate
active
07872042
ABSTRACT:
The present invention provides methods for elevating IKBKAP gene expression and the level of functional IKAP protein in cells, which are beneficial to human individual, such as an individual suffering from Familial Dysautonomia, by providing one or more tocotrienols alone or in combination with one or more tocopherols to the cells. The present invention also provides methods for treating Familial Dysautonomia by providing tocotrienols alone or in combination with one or more tocopherols to a patient having Familial Dysautonomia. Related therapeutic kits are also provided.
REFERENCES:
patent: WO 96/19218 (1996-06-01), None
patent: WO 00/78296 (2000-12-01), None
patent: WO 2005/009135 (2005-02-01), None
Nesaretnam et al Abstract Lipids 1998 33 461.
Chatelain et. al., Biochimica et Biophysica Acta, 1993, Elsevier Science Ltd., vol. 1176, pp. 83-89.
Anderson Sylvia L.
Rubin Berish Y.
Padmanabhan Sreeni
Pihonak Sarah
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Use of tocotrienols for elevating IKBKAP gene expression... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tocotrienols for elevating IKBKAP gene expression..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tocotrienols for elevating IKBKAP gene expression... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2701248